XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenue $ 4,742 $ 4,151 $ 13,259 $ 11,634
Cost of revenue (COR) 2,019 1,677 5,648 4,854
Gross profit 2,723 2,474 7,611 6,780
Research and development (R&D) 518 492 1,562 1,468
Selling, general and administrative (SG&A) 457 428 1,414 1,348
Restructuring charges/other 85 0 85 (124)
Operating profit 1,663 1,554 4,550 4,088
Other income (expense), net (OI&E) 62 131 190 384
Interest and debt expense 141 131 402 378
Income before income taxes 1,584 1,554 4,338 4,094
Provision for income taxes 220 192 500 500
Net income $ 1,364 $ 1,362 $ 3,838 $ 3,594
Earnings per common share (EPS):        
Basic (in dollars per share) $ 1.49 $ 1.48 $ 4.20 $ 3.92
Diluted (in dollars per share) $ 1.48 $ 1.47 $ 4.18 $ 3.89
Average shares outstanding:        
Basic (in shares) 909 913 909 912
Diluted (in shares) 914 920 914 919
Diluted EPS:        
Net income $ 1,364 $ 1,362 $ 3,838 $ 3,594
Income allocated to RSUs (8) (7) (21) (18)
Income allocated to common stock for diluted EPS $ 1,356 $ 1,355 $ 3,817 $ 3,576